These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33791883)

  • 21. Develop adult extrapolation to pediatrics and pediatric dose optimization based on the physiological pharmacokinetic model of azithromycin.
    Liang L; Li W; Zhang Z; Li D; Pu S; Xiang R; Zhai F
    Biopharm Drug Dispos; 2023 Jun; 44(3):245-258. PubMed ID: 37080927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological parameter values for physiologically based pharmacokinetic models in food-producing animals. Part I: Cattle and swine.
    Lin Z; Li M; Wang YS; Tell LA; Baynes RE; Davis JL; Vickroy TW; Riviere JE
    J Vet Pharmacol Ther; 2020 Sep; 43(5):385-420. PubMed ID: 32270548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years.
    Edginton AN; Shah B; Sevestre M; Momper JD
    Clin Pharmacokinet; 2013 Aug; 52(8):693-703. PubMed ID: 23588537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.
    Vogt W
    Clin Pharmacokinet; 2014 Jan; 53(1):51-72. PubMed ID: 23839530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry.
    Bosgra S; van Eijkeren J; Bos P; Zeilmaker M; Slob W
    Crit Rev Toxicol; 2012 Oct; 42(9):751-67. PubMed ID: 22954170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.
    Stader F; Siccardi M; Battegay M; Kinvig H; Penny MA; Marzolini C
    Clin Pharmacokinet; 2019 Apr; 58(4):483-501. PubMed ID: 30128967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth and organ development.
    Cole TJ
    Adv Exp Med Biol; 2009; 639():1-13. PubMed ID: 19227530
    [No Abstract]   [Full Text] [Related]  

  • 29. Predicting pediatric age-matched weight and body mass index.
    Sy SK; Asin-Prieto E; Derendorf H; Samara E
    AAPS J; 2014 Nov; 16(6):1372-9. PubMed ID: 25155824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Preterm Physiologically Based Pharmacokinetic Model. Part I: Physiological Parameters and Model Building.
    Abduljalil K; Pan X; Pansari A; Jamei M; Johnson TN
    Clin Pharmacokinet; 2020 Apr; 59(4):485-500. PubMed ID: 31583613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model.
    Yang F; Tong X; McCarver DG; Hines RN; Beard DA
    J Pharmacokinet Pharmacodyn; 2006 Aug; 33(4):485-518. PubMed ID: 16758333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89.
    Ann ICRP; 2002; 32(3-4):5-265. PubMed ID: 14506981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A population physiologically-based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab.
    Chang HP; Shakhnovich V; Frymoyer A; Funk RS; Becker ML; Park KT; Shah DK
    Br J Clin Pharmacol; 2022 Jan; 88(1):290-302. PubMed ID: 34189743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
    Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
    Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.
    Willmann S; Becker C; Burghaus R; Coboeken K; Edginton A; Lippert J; Siegmund HU; Thelen K; Mück W
    Clin Pharmacokinet; 2014 Jan; 53(1):89-102. PubMed ID: 23912563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Application of a Physiologically-Based Pharmacokinetic Model to Predict the Pharmacokinetics of Therapeutic Proteins from Full-term Neonates to Adolescents.
    Pan X; Stader F; Abduljalil K; Gill KL; Johnson TN; Gardner I; Jamei M
    AAPS J; 2020 May; 22(4):76. PubMed ID: 32449129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach.
    Rasool MF; Khalid R; Imran I; Majeed A; Saeed H; Alasmari F; Alanazi MM; Alqahtani F
    Drug Metab Dispos; 2020 Jul; 48(7):570-579. PubMed ID: 32393652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing pharmacokinetic bridging studies in paediatric oncology using physiologically-based pharmacokinetic modelling: application to docetaxel.
    Thai HT; Mazuir F; Cartot-Cotton S; Veyrat-Follet C
    Br J Clin Pharmacol; 2015 Sep; 80(3):534-47. PubMed ID: 26095234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive Pediatric Modeling and Simulation Using Ontogeny Information.
    Ince I; Solodenko J; Frechen S; Dallmann A; Niederalt C; Schlender J; Burghaus R; Lippert J; Willmann S
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S95-S103. PubMed ID: 31502689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization.
    Zheng L; Xu M; Tang SW; Song HX; Jiang XH; Wang L
    Pharm Res; 2019 Oct; 36(12):171. PubMed ID: 31654287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.